SMTI
HealthcareSanara MedTech Inc
Live · NASDAQ · May 9, Close
What's Moving SMTI Today?
No stock-specific AI insight has been generated for SMTI yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
SMTI News
20 articles- ICU Medical (ICUI) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 7, 2026
- Insulet (PODD) Q1 Earnings and Revenues Top EstimatesYahoo Finance·May 6, 2026
- How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 TargetYahoo Finance·May 5, 2026
- Sanara MedTech (SMTI) Q4 2025 Earnings TranscriptMotley Fool·May 4, 2026
- What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?Yahoo Finance·Apr 23, 2026
- How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth AssumptionsYahoo Finance·Apr 20, 2026
- Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026Yahoo Finance·Apr 14, 2026
- Sanara MedTech Inc. Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...Yahoo Finance·Mar 24, 2026
- Sanara MedTech Q4 Earnings Call HighlightsMarketbeat·Mar 24, 2026
- Sanara MedTech Inc. (SMTI) Q4 Earnings Miss EstimatesYahoo Finance·Mar 24, 2026
- Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial GuidanceYahoo Finance·Mar 24, 2026
- Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery WoundsYahoo Finance·Mar 11, 2026
- Evolus, Inc. (EOLS) Matches Q4 Earnings EstimatesYahoo Finance·Mar 3, 2026
- Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026Yahoo Finance·Mar 3, 2026
- Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rdYahoo Finance·Feb 17, 2026
- Shareholders in Sanara MedTech (NASDAQ:SMTI) are in the red if they invested three years agoYahoo Finance·Feb 13, 2026
- Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial GuidanceYahoo Finance·Jan 23, 2026
- Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical SolutionYahoo Finance·Jan 7, 2026
- Sanara MedTech (SMTI) Upgraded to Strong Buy: Here's What You Should KnowYahoo Finance·Jan 6, 2026
All 20 articles loaded
Price Data
Fundamentals
Trading
About Sanara MedTech Inc
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.